Inhibitors of secretion of hepatitis B virus antigens
US8921381B2 · kind B2 · utility
1Cited by
2References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 4, 2011 |
| Grant date | Dec 30, 2014 |
| Priority date | — |
| Expiry date | Oct 4, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions of the invention comprise triazolopyrimidines useful for the treatment of hepatitis virus in a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.